Squeeze

Item 7 lays out the steep initial investment of $534,150 to $1,284,500, including a $50,000 franchise fee, driven by buildout in retail spaces and tech integrations like adjustable therapy rooms. Ongoing fees hit hard: 6% royalty on gross sales, 2% brand fund, plus fixed $1,625 monthly local marketing, $280 weekly guest experience, and $450 weekly technology—potentially exceeding 10% of revenue for underperformers. Item 19 shines brightly here, reporting average and median gross revenues of $689,813 across existing units, suggesting solid top-line potential in a competitive spa sector, though without per-unit breakdowns or expense details, profitability remains a black box.

System health metrics paint a mixed but promising portrait: from 2 franchise locations in 2022 to 7 in 2023 (+250% growth), with 16 projected new units signaling franchisor confidence. One corporate-owned store anchors the model, and 36 SBA loans averaging $426,575 indicate lender buy-in despite the youth (only 8 total locations). No red flags on terminations or transfers in recent FDDs, but the tiny footprint means limited track record—ideal for early adopters betting on Nashville-based expansion, riskier for conservative investors eyeing proven scale.